A. Wang

793 total citations
15 papers, 577 citations indexed

About

A. Wang is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, A. Wang has authored 15 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Orthopedics and Sports Medicine, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in A. Wang's work include Bone health and osteoporosis research (10 papers), Bone health and treatments (9 papers) and Bone Metabolism and Diseases (6 papers). A. Wang is often cited by papers focused on Bone health and osteoporosis research (10 papers), Bone health and treatments (9 papers) and Bone Metabolism and Diseases (6 papers). A. Wang collaborates with scholars based in United States, Canada and Switzerland. A. Wang's co-authors include Michael R. McClung, E. Michael Lewiecki, Paul D. Miller, Kurt Lippuner, Jonathan D. Adachi, Ove Törring, John C. Gallagher, Cesar Libanati, Steven Boonen and Z. Man and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Bone and Mineral Research and Annals of the Rheumatic Diseases.

In The Last Decade

A. Wang

14 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Wang United States 8 447 371 249 145 61 15 577
Ruvie L. Martinez United States 5 451 1.0× 394 1.1× 174 0.7× 164 1.1× 32 0.5× 5 595
Folorunsho Edobor‐Osula United States 8 612 1.4× 501 1.4× 76 0.3× 290 2.0× 137 2.2× 22 798
JD Adachi Canada 6 292 0.7× 106 0.3× 80 0.3× 130 0.9× 42 0.7× 7 378
Denise Greene United States 9 562 1.3× 282 0.8× 59 0.2× 385 2.7× 192 3.1× 9 731
Liviu Macovei Romania 7 237 0.5× 213 0.6× 103 0.4× 59 0.4× 28 0.5× 27 347
Emese Tóth Belgium 8 180 0.4× 61 0.2× 56 0.2× 113 0.8× 65 1.1× 15 313
Gustaf Ortsäter Sweden 9 179 0.4× 47 0.1× 34 0.1× 132 0.9× 40 0.7× 18 293
Waleed Hassan Egypt 9 51 0.1× 56 0.2× 38 0.2× 72 0.5× 23 0.4× 63 314
Pamela Dilworth Australia 11 94 0.2× 114 0.3× 35 0.1× 240 1.7× 178 2.9× 12 477
Z Ortiz Argentina 6 82 0.2× 32 0.1× 34 0.1× 40 0.3× 31 0.5× 11 306

Countries citing papers authored by A. Wang

Since Specialization
Citations

This map shows the geographic impact of A. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Wang more than expected).

Fields of papers citing papers by A. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Wang. The network helps show where A. Wang may publish in the future.

Co-authorship network of co-authors of A. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of A. Wang. A scholar is included among the top collaborators of A. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Wang. A. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ferrari, Serge, Cesar Libanati, Celia J. F. Lin, et al.. (2019). Relationship Between Bone Mineral Density T-Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment. Journal of Bone and Mineral Research. 34(6). 1033–1040. 77 indexed citations
2.
Kendler, David L., Arkadi Chines, Maria Luisa Brandi, et al.. (2018). The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies. Osteoporosis International. 30(1). 71–78. 16 indexed citations
3.
McClung, Michael R., et al.. (2017). Observations following discontinuation of long-term denosumab therapy. Osteoporosis International. 28(5). 1723–1732. 157 indexed citations
4.
McClung, Michael R., Kurt Lippuner, Maria Luisa Brandi, et al.. (2017). Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis. Osteoporosis International. 28(10). 2967–2973. 37 indexed citations
5.
Silverman, Stuart L., A. Wang, Leonard K. Cheng, et al.. (2015). Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis. Osteoporosis International. 27(1). 75–80. 3 indexed citations
6.
Palacios, Santiago, René Rizzoli, Carol Zapalowski, et al.. (2015). Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis. Climacteric. 18(6). 805–812. 20 indexed citations
7.
Ferrari, Serge, Jonathan D. Adachi, Kurt Lippuner, et al.. (2015). Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years. Osteoporosis International. 26(12). 2763–2771. 52 indexed citations
8.
Papapoulos, Socrates E., Christian Roux, Henry G. Bone, et al.. (2015). FRI0289 Denosumab Treatment in Postmenopausal Women with Osteoporosis for Up to 9 Years: Results Through Year 6 of the Freedom Extension. Annals of the Rheumatic Diseases. 74. 529–530. 3 indexed citations
9.
Roux, Christian, Kurt Lippuner, Henry G. Bone, et al.. (2013). OP0250 Denosumab Treatment of Postmenopausal Women with Osteoporosis for 7 Years: Clinical Fracture Results from the First 4 Years of the Freedom Extension. Annals of the Rheumatic Diseases. 72. A137–A137. 7 indexed citations
10.
Clarke, Karen, Yi Pan, Kirk A. Easley, et al.. (2012). Reduction in catheter-associated urinary tract infections by bundling interventions. International Journal for Quality in Health Care. 25(1). 43–49. 41 indexed citations
11.
Törring, Ove, James A. Simon, Chris Recknor, et al.. (2012). Denosumab effects on radius BMD, estimated strength, and wrist fractures: 3-year results from the FREEDOM study. Bone. 50. S54–S55.
12.
Törring, Ove, Jacques P. Brown, Jens‐Erik Beck Jensen, et al.. (2012). OP0037 Denosumab discontinuation and associated fracture incidence: Analysis from the freedom trial. Annals of the Rheumatic Diseases. 71. 65–65. 1 indexed citations
13.
Boonen, Steven, Jonathan D. Adachi, Z. Man, et al.. (2011). Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk. The Journal of Clinical Endocrinology & Metabolism. 96(6). 1727–1736. 157 indexed citations
14.
Grazette, Luanda, Suresh Siddhanti, Nadia Daizadeh, et al.. (2010). Effect of denosumab on 3-year progression of aortic calcification in postmenopausal women with osteoporosis at high risk for cardiovascular events. Bone. 47. S69–S69. 2 indexed citations
15.
Lewiecki, E. Michael, Paul D. Miller, Michael R. McClung, et al.. (2006). Denosumab (AMG 162) Inhibition of Rank Ligand Increases Bone Mineral Density After Two Years of Treatment in Postmenopausal Women with Low Bone Mineral Density. Journal of Clinical Densitometry. 9(2). 243–244. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruvie L. Martinez Breakdown of academic impact, for papers by Folorunsho Edobor‐Osula Breakdown of academic impact, for papers by JD Adachi Breakdown of academic impact, for papers by Denise Greene Breakdown of academic impact, for papers by Liviu Macovei Breakdown of academic impact, for papers by Emese Tóth Breakdown of academic impact, for papers by Gustaf Ortsäter Breakdown of academic impact, for papers by Waleed Hassan Breakdown of academic impact, for papers by Pamela Dilworth Breakdown of academic impact, for papers by Z Ortiz
Rankless by CCL
2026